Finally, to validate the clinical relevance of TPL2 kinase action in human ADI prostate cancer growth, we examined the frequency of TPL2 expression in ADI human prostate cancer specimens using tissue microarrays (TMA). This evidence concerns the gene MAP3K8 and prostate cancer.